Methylene Blue (Akorn, Inc.)


Welcome to the PulseAid listing for the Methylene Blue drug offered from Akorn, Inc.. This Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn, Inc.
NON-PROPRIETARY NAME: Methylene Blue
SUBSTANCE NAME: METHYLENE BLUE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Oxidation-Reduction Agent [EPC],Oxidation-Reduction Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2009-04-01
END MARKETING DATE: 0000-00-00


Methylene Blue HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMethylene Blue from Akorn, Inc.
LABELER NAME: Akorn, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2009-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-504_a9e3194b-34a3-4012-9f1e-ac30e3e31377
PRODUCT NDC: 17478-504
APPLICATION NUMBER:

Other METHYLENE BLUE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Methylene Blue
American RegentPROVAYBLUE
General Injectables & Vaccines, IncMethylene Blue